Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × rocakinogene sifuplasmid × Clear all

NCT02514213 2017-12-26

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms